[The tumor markers TPA and CEA in the after care of breast cancer].
265 patients with operated and irradiated carcinoma of the breast have been followed up by serum Tissue Polypeptide Antigen (TPA) and Carcinoembryonic Antigen (CEA) analysis during a 6 month period. The results have been compared with those of our routine follow-up-program and the clinical observations. It could be demonstrated, that TPA and CEA serum levels cannot be used as indicators for an early detection of recurrent cancer or the beginning of progressive metastases. The results are contrary to those in the literature.
Beaufort
F
F
Fueger
G F
GF
Steiner
H
H
D000359:Aftercare; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000276:immunology; D002272:Carcinoembryonic Antigen / Q000032:analysis*; D005189:False Positive Reactions; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis / Q000175:diagnosis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D010455:Peptides / Q000032:analysis*; D011863:Radioimmunoassay; D019396:Tissue Polypeptide Antigen
D002272:Carcinoembryonic Antigen; D010455:Peptides; D019396:Tissue Polypeptide Antigen
Die Tumormarker TPA und CEA in der Nachsorge des Mammakarzinoms.